Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Lettmann Jason, Director. Director active across 1 company, notably ALX Oncology Holdings INC. Aggregated, 12 disclosures have been recorded. Split: 2 buys · 6 sells. Total volume traded: €1.4m. Activity tracked since 8 December 2021. The latest transaction was disclosed on 17 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Lettmann Jason
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
35,836 shares@ US$33.2374.2% of flowCommon StockSEC:0001209191-21-069154:0
12 of 12 declarations
About Lettmann Jason
Jason Lettmann is Administrateur and Chief Executive Officer at ALX Oncology Holdings INC, listed on XNAS. He has 11 filings, and across the 11 sampled filings from 2021-12-10 to 2026-03-23, the aggregated amounts show EUR 64351 of buys and EUR 1350072 of sells; the most common transaction nature is Sale.